Brain & Cranial Neurosurgery

Brain Tumor Surgery in Bhubaneswar

Microsurgical Resection with Functional Pathway Preservation

Brain tumor surgery demands meticulous neurosurgical precision to achieve maximum safe cytoreduction while preserving critical neurological function. Dr. Sanatan Satapathy utilizes high-power operative microscopy, intraoperative neuronavigation (cranial GPS), and neurophysiological monitoring to perform tailored craniotomies for both benign (meningiomas, acoustic neuromas) and malignant neoplasms (gliomas, metastatic lesions).

Medically Reviewed & Verified Content
Published: November 15, 2024•Last Reviewed: January 10, 2025
Dr. Sanatan Satapathy, MBBS, MS, MCh (Neurosurgery) - Medical Reviewer
Author & Medical ReviewerNMC Reg. / OMC Recognized

Dr. Sanatan Satapathy, MBBS, MS, MCh (Neurosurgery)

Senior Consultant Neurosurgeon & Spine Care Specialist

Super-speciality MCh Neurosurgery from SCB Medical College, Cuttack; Advanced Microsurgical Fellowship at AIIMS New Delhi. Consultant at MAX Super Speciality Hospital (Formerly Kalinga Hospital), Bhubaneswar.

Editorial Standard & Clinical Guidelines Adherence

This clinical resource on Brain Tumor Surgery was authored and clinically vetted by Dr. Sanatan Satapathy in accordance with evidence-based neurosurgical guidelines published by the Neurological Society of India (NSI), the Congress of Neurological Surgeons (CNS), and the North American Spine Society (NASS).

Understanding the Condition & Surgical Indication

A brain tumor is an abnormal proliferation of cellular mass within the rigid intracranial cavity. As the tumor expands, it increases intracranial pressure (ICP) and compresses or infiltrates functional brain pathways, causing progressive neurological impairment.

When to Seek Specialist Neurosurgical Evaluation

Immediate neurosurgical evaluation is advised if experiencing persistent morning headaches accompanied by vomiting, newly onset adult seizures, progressive limb weakness, unilateral vision disturbances, speech difficulties, or sudden personality changes.

Available Surgical Approaches & Technology

Surgical options include frameless neuronavigation craniotomy, awake craniotomy with cortical speech mapping for lesions near eloquent cortex, and endoscopic transsphenoidal removal for pituitary tumors.

Approach 01

Neuronavigation-Guided Craniotomy

Precision 3D optical tracking correlates pre-operative MRI scans with the surgical field, allowing sub-centimeter accuracy in localized tumor localization.

Approach 02

Intraoperative Neuromonitoring (IONM)

Continuous electrophysiological monitoring of motor evoked potentials (MEP) and somatosensory evoked potentials (SSEP) to protect nerve conduits.

Approach 03

Cavitron Ultrasonic Surgical Aspiration (CUSA)

Fragmenting and aspirating tumor tissue at ultrasonic frequencies while sparing adjacent blood vessels and delicate brain parenchyma.

How the Procedure Is Performed

Under general anesthesia or awake protocols, a small, customized bone window (craniotomy) is created directly over the lesion. Using ultrasonic surgical aspirators (CUSA) and micro-instruments, the tumor is systematically detached from surrounding neural tissue under continuous neuro-monitoring.

Potential Benefits & Clinical Limitations

Potential benefits include immediate reduction of intracranial mass effect, relief of neurological symptoms, and obtaining accurate histopathological and molecular tissue typing for targeted therapy. Limitations depend on tumor invasiveness into eloquent motor or speech pathways where complete excision might carry neurological risk.

Clinical Indications for Surgery

Malignant gliomas (Glioblastoma, Astrocytoma, Oligodendroglioma)
Benign meningiomas (convexity, parasagittal, skull base)
Pituitary adenomas causing endocrine disturbance or visual field loss
Vestibular Schwannomas (Acoustic Neuromas) causing hearing loss or tinnitus
Metastatic brain lesions causing localized mass effect
Intraventricular tumors causing obstructive hydrocephalus

Surgical Eligibility Criteria

  • Histologically suspected or confirmed space-occupying lesion with mass effect
  • Focal neurological deficits corresponding to radiographic tumor coordinates
  • Intractable epilepsy associated with structural brain neoplasms
  • Lesions with surrounding vasogenic edema causing midline shift

Post-Operative Recovery Timeline

Patients typically stay in hospital for 4 to 6 days. Follow-up imaging and coordinated oncological care are tailored to the definitive histopathological diagnosis.

1

Neuro-ICU Surveillance (Hours 0–48)

Continuous hourly Glasgow Coma Scale (GCS) checks, arterial line blood pressure regulation, and pupillary monitoring.

2

Step-Down Mobilization (Days 3–5)

Neuro-physiotherapy, assisted ambulation, transition to oral medications, and baseline postoperative MRI verification.

3

Surgical Wound Review (Weeks 2–3)

Suture or staple removal, histopathology review with multidisciplinary tumor board, and planning adjuvant therapy if indicated.

4

Long-Term Rehabilitation (Months 2–3+)

Gradual resumption of occupational duties, cognitive rehabilitation, and periodic surveillance MRI scans.

Frequently Asked Questions

Are all brain tumors cancerous?

No. A substantial percentage of brain tumors, such as meningiomas, schwannomas, and pituitary adenomas, are histologically benign. However, because the skull has a fixed volume, benign tumors often still require surgical decompression to relieve pressure on the brain.

How does the surgeon know where the brain tumor ends and healthy brain begins?

Through high-definition operative microscopes, real-time neuronavigation (cranial GPS), and intraoperative physiological mapping that tests motor and sensory signals before tissue is removed.

What is the typical hospital stay after brain tumor surgery?

Most planned craniotomy patients spend 24 to 48 hours in the specialized Neuro-ICU for continuous monitoring, followed by 3 to 4 days in a private room before safe discharge.

Scientific References & Clinical Guidelines

Peer-reviewed neurosurgical literature and consensus statements informing this guide

[1]The 2021 WHO Classification of Tumors of the Central Nervous System

Neuro-Oncology • 2021 • Louis DN, Perry A, Wesseling P, et al.

Clinical Context: Defines modern histological and molecular diagnostic standards for intracranial tumors.

[2]Effects of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy Alone on Survival in Glioblastoma

New England Journal of Medicine (NEJM) • 2005 • Stupp R, Mason WP, van den Bent MJ, et al.

Clinical Context: Establishes standard of care multidisciplinary management after surgical cytoreduction.

Evidence Statement: All numerical claims, recovery estimates, and treatment algorithms are synthesized from prospective trials, multi-center registry data, and clinical guidelines established by the Neurological Society of India (NSI), the North American Spine Society (NASS), and the Congress of Neurological Surgeons (CNS).
Brain Tumor Surgery

Consult for Brain Tumor Surgery

Consult with Dr. Sanatan Satapathy at MAX Super Speciality Hospital (Formerly Kalinga Hospital), Chandrasekharpur, Bhubaneswar.

Schedule Appointment

Procedure Profile

Surgical Guidance:3D Neuronavigation
Intraoperative Monitoring:MEP / SSEP / EEG
Hospital Stay:4–6 Days
Tumor Staging:WHO CNS 2021 Criteria

Related Patient Guide

Explore Brain Tumour Guide
Specialist Consultation Desk

Your Journey Towards Better Neurological Care Starts Here.

Schedule a consultation to discuss your symptoms, concerns and available treatment options with Dr. Sanatan Satapathy.

Call DeskWhatsAppBook OPD